Consolidated Financial Results for The Year 2019 For the year ended December 31st, 2019 Consolidated Profit & Loss of Global Consumer Public Company Limited Unit: Million Baht Y 2019 Y 2018 Change %YoY Revenues
the year ended 31 December 2017 and 2016 are as follows; Unit: THB million Y2017 Y2016 % Change 1. Revenue from sales and contract work 21.4 87.7 -75.6% 1.1 Turnkey Total Solutions 21.4 87.7 -75.6% 2
of the market competition both of the competitor and the pricing, some project could not continue to extend the services. However, the Private sector’s customer has continued growth, both from new
administrative expenses are as follows: Q-O-Q Change Increase/(Decrease) Q3/2017 Q3/2018 Selling expenses 3.9 5.6 43.6% Mainly caused from the sale promotion expenses and advertising expenses increase
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
Financial and Operating Highlights * ไม่รวมต้นทุนค่าเสื่อมราคาและค่าตัดจ าหน่าย Operating highlight in Q4/2018 and 2018 Q4/17 Q3/18 Q4/18 Change +/(-) 2017 2018 Change +/(-) (THB million) QoQ YoY YoY
Financial and Operating Highlights * ไม่รวมต้นทุนค่าเสื่อมราคาและค่าตัดจ าหน่าย Operating highlight in Q4/2018 and 2018 Q4/17 Q3/18 Q4/18 Change +/(-) 2017 2018 Change +/(-) (THB million) QoQ YoY YoY
Inventory gains/(losses) 4Core Net Profit is Reported Net Profit less Inventory gains/(losses) one-time extraordinary items 5Operating Cash Flow is after change in net working capital and cash tax, before
EBITDA less Inventory gains/(losses) 4Core Net Profit is Reported Net Profit less Inventory gains/(losses) one-time extraordinary items 5Operating Cash Flow is after change in net working capital and cash
change in net working capital and cash tax, before maintenance capex Indorama Ventures 2nd Quarter 2019 MD&A 3 Summary 2Q19 results IVL’s performance for the first half and ongoing progress give us the